Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: Association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels

AIDS Research and Human Retroviruses

Volumn 15, Issue 1, 1999, Pages 51-55

  Min, Juno ^a   Katzenstein, David A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; VIRUS DNA; VIRUS RNA;

ARTICLE; DISEASE ASSOCIATION; FEMALE; HERPES VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SERODIAGNOSIS; SEX DIFFERENCE; UNITED STATES; VIRUS DETECTION; VIRUS EXPRESSION; VIRUS REPLICATION;

ADULT; CAPSID; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RNA, VIRAL; SARCOMA, KAPOSI; VIRAL LOAD;

EID: 0032928687     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299311709     Document Type: Article

References (16)

1. Beral V, Peterman TA, Berkelman RL, and Jaffe HW: Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection? Lancet 1990;335:123-127.
2. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, and Moore PS: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865-1869.
3. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee J, Weiss RA, and O'Leary JJ: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995;1:1274-1278.
4. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, and Schulz TF: Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995;346:799-802.
5. Moore PS, Kingsley LA, Holmberg SD, Spira T, Gupta P, Hoover DR, Parry JP, Conley LJ, Jaffe HW, and Chang Y: Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996;10:175-180.
6. Smith MS, Bloomer C, Horvat R, Goldstein E, Casparian JM, and Chandran B: Detection of human herpesvirus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997;176:84-93.
7. Viviano E, Vitale F, Ajello F, Perna AM, Villafrate MR, Bonura F, Arico M, Mazzola G, and Romano N: Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negalive individuals in Sicily. AIDS 1997;11:607-612.
8. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, and Chang Y: In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995;86:2708-2714.
9. Moore PS and Chang Y: Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. N Engl J Med 1995;332:1181-1185.
10. Lennette ET, Blackbourn DJ, and Levy JA: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-861.
11. Kedes DH, Ganem D, Ameli N, Bacchetti P, and Greenblatt R: The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 1997;277:478-481.
12. Rabkin CS, Schilz TF, Whitby D, Lennette ET, Magpantay LJ, Chatlynne L, and Bikggar R: Interassay correlation of human herpes virus 8 serologic tests. J Infect Dis 1998;178:304-309.
13. Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, and Venuta S: Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. J Virol 1993;67:2853-2861.
14. Mole L, Ripich S, Margolis D, and Holodniy M: The impact of active herpes simplex virus infection on human immunodeficiency virus load. J Infect Dis 1997;176:766-770.
15. Pleskoff O, Tréboute C, Brelot A, Heveker N, Seman M, and Alizon M: Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997;276:1874-1878.
16. Penn I: Secondary neoplasms as a consequence of transplantation and cancer therapy. Cancer Detect Prev 1988;12:39-57.